BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 10356144)

  • 1. Influence of severe combined immunodeficiency phenotype on the outcome of HLA non-identical, T-cell-depleted bone marrow transplantation: a retrospective European survey from the European group for bone marrow transplantation and the european society for immunodeficiency.
    Bertrand Y; Landais P; Friedrich W; Gerritsen B; Morgan G; Fasth A; Cavazzana-Calvo M; Porta F; Cant A; Espanol T; Müller S; Veys P; Vossen J; Haddad E; Fischer A
    J Pediatr; 1999 Jun; 134(6):740-8. PubMed ID: 10356144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients.
    Haddad E; Landais P; Friedrich W; Gerritsen B; Cavazzana-Calvo M; Morgan G; Bertrand Y; Fasth A; Porta F; Cant A; Espanol T; Müller S; Veys P; Vossen J; Fischer A
    Blood; 1998 May; 91(10):3646-53. PubMed ID: 9573000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
    Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA non-identical T-cell-depleted bone marrow transplantation for primary immunodeficiency diseases.
    Giri N; Vowels M; Ziegler JB; Ford D; Lam-Po-Tang R
    Aust N Z J Med; 1994 Feb; 24(1):26-30. PubMed ID: 8002854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European experience of bone-marrow transplantation for severe combined immunodeficiency.
    Fischer A; Landais P; Friedrich W; Morgan G; Gerritsen B; Fasth A; Porta F; Griscelli C; Goldman SF; Levinsky R
    Lancet; 1990 Oct; 336(8719):850-4. PubMed ID: 1976883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term chimerism and B-cell function after bone marrow transplantation in patients with severe combined immunodeficiency with B cells: A single-center study of 22 patients.
    Haddad E; Le Deist F; Aucouturier P; Cavazzana-Calvo M; Blanche S; De Saint Basile G; Fischer A
    Blood; 1999 Oct; 94(8):2923-30. PubMed ID: 10515898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow transplantation for T-B- severe combined immunodeficiency disease in Athabascan-speaking native Americans.
    O'Marcaigh AS; DeSantes K; Hu D; Pabst H; Horn B; Li L; Cowan MJ
    Bone Marrow Transplant; 2001 Apr; 27(7):703-9. PubMed ID: 11360109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes of nonconditioned patients with severe combined immunodeficiency transplanted with HLA-identical or haploidentical bone marrow depleted of T cells with anti-CD6 mAb.
    Patel NC; Chinen J; Rosenblatt HM; Hanson IC; Brown BS; Paul ME; Abramson SL; Ritz J; Shearer WT
    J Allergy Clin Immunol; 2008 Dec; 122(6):1185-93. PubMed ID: 19084111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CAMPATH-1M T-cell depleted BMT for SCID: long-term follow-up of 19 children treated 1987-98 in a single center.
    Gennery AR; Dickinson AM; Brigham K; Barge D; Spickett GP; Curtis A; Spencer V; Jackson A; Cavanagh G; Carter V; Palmer P; Flood TJ; Cant AJ; Abinun M
    Cytotherapy; 2001; 3(3):221-32. PubMed ID: 12171729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplantation of X-linked severe combined immunodeficient dogs with CD34+ bone marrow cells.
    Hartnett BJ; Yao D; Suter SE; Ellinwood NM; Henthorn PS; Moore PE; McSweeney PA; Nash RA; Brown JD; Weinberg KI; Felsburg PJ
    Biol Blood Marrow Transplant; 2002; 8(4):188-97. PubMed ID: 12014808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of EBV-induced B-lymphoproliferative disorder by ex vivo marrow B-cell depletion in HLA-phenoidentical or non-identical T-depleted bone marrow transplantation.
    Cavazzana-Calvo M; Bensoussan D; Jabado N; Haddad E; Yvon E; Moskwa M; Tachet des Combes A; Buisson M; Morand P; Virion JM; Le Deist F; Fischer A
    Br J Haematol; 1998 Nov; 103(2):543-51. PubMed ID: 9827933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of graft failure by a monoclonal antibody (anti-LFA-1 CD11a) after HLA nonidentical bone marrow transplantation in children with immunodeficiencies, osteopetrosis, and Fanconi's anemia: a European Group for Immunodeficiency/European Group for Bone Marrow Transplantation report.
    Fischer A; Friedrich W; Fasth A; Blanche S; Le Deist F; Girault D; Veber F; Vossen J; Lopez M; Griscelli C
    Blood; 1991 Jan; 77(2):249-56. PubMed ID: 1985691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.
    Buckley RH; Schiff SE; Schiff RI; Markert L; Williams LW; Roberts JL; Myers LA; Ward FE
    N Engl J Med; 1999 Feb; 340(7):508-16. PubMed ID: 10021471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell depleted haploidentical bone marrow transplantation for the treatment of children with severe combined immunodeficiency.
    Smogorzewska EM; Brooks J; Annett G; Kapoor N; Crooks GM; Kohn DB; Parkman R; Weinberg KI
    Arch Immunol Ther Exp (Warsz); 2000; 48(2):111-8. PubMed ID: 10807052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow transplantation for severe combined immune deficiency.
    Grunebaum E; Mazzolari E; Porta F; Dallera D; Atkinson A; Reid B; Notarangelo LD; Roifman CM
    JAMA; 2006 Feb; 295(5):508-18. PubMed ID: 16449616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune reconstitution in severe combined immunodeficiency disease after lectin-treated, T-cell-depleted haplocompatible bone marrow transplantation.
    Dror Y; Gallagher R; Wara DW; Colombe BW; Merino A; Benkerrou M; Cowan MJ
    Blood; 1993 Apr; 81(8):2021-30. PubMed ID: 8471764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matched unrelated bone marrow transplantation for combined immunodeficiency.
    Dalal I; Reid B; Doyle J; Freedman M; Calderwood S; Saunders F; Roifman CM
    Bone Marrow Transplant; 2000 Mar; 25(6):613-21. PubMed ID: 10734295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reticular dysgenesis: HLA non-identical bone marrow transplants in a series of 10 patients.
    Bertrand Y; Müller SM; Casanova JL; Morgan G; Fischer A; Friedrich W
    Bone Marrow Transplant; 2002 May; 29(9):759-62. PubMed ID: 12040473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating red cells usually remain of host origin after bone marrow transplantation for severe combined immunodeficiency.
    Brady KA; Cowan MJ; Leavitt AD
    Transfusion; 1996 Apr; 36(4):314-7. PubMed ID: 8623130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of natural killer cell killer Ig-like receptor alloreactivity on the outcome of bone marrow stem cell transplantation for severe combined immunodeficiency (SCID).
    Keller MD; Chen DF; Condron SA; Liu N; Reinsmoen NL; Buckley RH
    J Clin Immunol; 2007 Jan; 27(1):109-16. PubMed ID: 17191149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.